SYMONS CAPITAL MANAGEMENT INC - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 3.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
SYMONS CAPITAL MANAGEMENT INC ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$37,000
-53.2%
14,346
-3.6%
0.02%
-46.7%
Q2 2021$79,000
-21.0%
14,8860.0%0.04%
-13.5%
Q1 2021$100,00014,8860.05%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 181,384$54,0000.23%
Samsara BioCapital, LLC 601,162$180,0000.05%
Board of Trustees of The Leland Stanford Junior University 688,701$207,0000.01%
Matisse Capital 36,800$11,0000.01%
Knights of Columbus Asset Advisors LLC 120,841$36,0000.00%
Covestor Ltd 11,972$4,0000.00%
Ergoteles LLC 219,461$66,0000.00%
Virtu Financial LLC 74,636$22,0000.00%
IPG Investment Advisors LLC 14,300$4,0000.00%
Aquatic Capital Management LLC 13,200$4,0000.00%
View complete list of KALA PHARMACEUTICALS INC shareholders